|
1
|
Wass JA and Karavitaki N: Nonfunctioning
pituitary adenomas: The oxford experience. Nat Rev Endocrinol.
5:519–522. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Capozzi A, Scambia G, Pontecorvi A and
Lello S: Hyperprolactinemia: Pathophysiology and therapeutic
approach. Gynecol Endocrinol. 31:506–510. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sakurai T, Seo H, Yamamoto N, Nagaya T,
Nakane T, Kuwayama A, Kageyama N and Matsui N: Detection of mRNA of
prolactin and ACTH in clinically nonfunctioning pituitary adenomas.
J Neurosurg. 69:653–659. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Beentjes JA, Tjeerdsma G, Sluiter WJ and
Dullaart RP: Divergence between growth hormone responses to
insulin-induced hypoglycaemia and growth hormone-releasing hormone
in patients with non-functioning pituitary macroadenomas and
hyperprolactinaemia. Clin Endocrinol (Oxf). 45:391–398. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fonseca AL, Chimelli L, Santos MJ, Santos
AA and Violante AH: Influence of hyperprolactinemia and tumoral
size in the postoperative pituitary function in clinically
nonfunctioning pituitary macroadenomas. Arq Neuropsiquiatr.
60:590–602. 2002.(In Portuguese). View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Karavitaki N, Thanabalasingham G, Shore
HC, Trifanescu R, Ansorge O, Meston N, Turner HE and Wass JA: Do
the limits of serum prolactin in disconnection hyperprolactinaemia
need re-definition? A study of 226 patients with histologically
verified non-functioning pituitary macroadenoma. Clin Endocrinol
(Oxf). 65:524–529. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cury ML, Fernandes JC, Machado HR, Elias
LL, Moreira AC and Castro Md: Non-functioning pituitary adenomas:
Clinical feature, laboratorial and imaging assessment, therapeutic
management and outcome. Arq Bras Endocrinol Metabol. 53:31–39.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Berkmann S, Fandino J, Muller B, Remonda L
and Landolt H: Intraoperative MRI and endocrinological outcome of
transsphenoidal surgery for non-functioning pituitary adenoma. Acta
Neurochir (Wien). 154:639–647. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Colao A, Di Somma C, Pivonello R, Faggiano
A, Lombardi G and Savastano S: Medical therapy for clinically
non-functioning pituitary adenomas. Endocr Relat Cancer.
15:905–915. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhao W, Ye H, Li Y, Zhou L, Lu B, Zhang S,
Wen J, Li S, Yang Y and Hu R: Thyrotropin-secreting pituitary
adenomas: Diagnosis and management of patients from one Chinese
center. Wien Klin Wochenschr. 124:678–684. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Behan LA, O'sullivan EP, Glynn N, Woods C,
Crowley RK, Tun TK, Smith D, Thompson CJ and Agha A: Serum
prolactin concentration at presentation of non-functioning
pituitary macroadenomas. J Endocrinol Invest. 36:508–514.
2013.PubMed/NCBI
|
|
12
|
Shimon I, Jallad RS, Fleseriu M, Yedinak
CG, Greenman Y and Bronstein MD: Giant GH-secreting pituitary
adenomas: Management of rare and aggressive pituitary tumors. Eur J
Endocrinol. 172:707–713. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ferrante E, Ferraroni M, Castrignanò T,
Menicatti L, Anagni M, Reimondo G, Del Monte P, Bernasconi D, Loli
P, Faustini-Fustini M, et al: Non-functioning pituitary adenoma
database: A useful resource to improve the clinical management of
pituitary tumors. Eur J Endocrinol. 155:823–829. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hong JW, Lee MK, Kim SH and Lee EJ:
Discrimination of prolactinoma from hyperprolactinemic
non-functioning adenoma. Endocrine. 37:140–147. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Melmed S, Casanueva FF, Hoffman AR,
Kleinberg DL, Montori VM, Schlechte JA and Wass JA; Endocrine
Society, : Diagnosis and treatment of hyperprolactinemia: An
Endocrine Society clinical practice guideline. J Clin Endocrinol
Metab. 96:273–288. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhu M, Zhang Y and Peng H: Comparative
Analysis and Clinical Application of Serum PRL and MRI Scan on
Pituitary Prolactinoma. J Radioimmunol. 2013.
|
|
17
|
Smith MV and Laws ER Jr: Magnetic
resonance imaging measurements of pituitary stalk compression and
deviation in patients with nonprolactin-secreting intrasellar and
parasellar tumors: Lack of correlation with serum prolactin levels.
Neurosurgery. 34:834–839. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Delellis RA: Pathology and genetics of
tumours of endocrine organs. IARC Press; 2004
|
|
19
|
Trouillas J, Roy P, Sturm N, Dantony E,
Cortet-Rudelli C, Viennet G, Bonneville JF, Assaker R, Auger C,
Brue T, et al: A new prognostic clinicopathological classification
of pituitary adenomas: A multicentric case-control study of 410
patients with 8 years post-operative follow-up. Acta Neuropathol.
126:123–135. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jan M, Dufour H, Brue T and Jaquet P:
Prolactinoma surgery. Ann Endocrinol (Paris). 68:118–119. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gruppetta M and Vassallo J: Epidemiology
and radiological geometric assessment of pituitary macroadenomas:
Population-based study. Clin Endocrinol (Oxf). 85:223–231. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Osamura RY, Kajiya H, Takei M, Egashira N,
Tobita M, Takekoshi S and Teramoto A: Pathology of the human
pituitary adenomas. Histochem Cell Biol. 130:495–507. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Barkan AL and Chandler WF: Giant pituitary
prolactinoma with falsely low serum prolactin: The pitfall of the
‘high-dose hook effect’: Case report. Neurosurgery. 42:913–916.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Petakov MS, Damjanović SS, Nikolić-Durović
MM, Dragojlović ZL, Obradović S, Gligorović MS, Simić MZ and
Popović VP: Pituitary adenomas secreting large amounts of prolactin
may give false low values in immunoradiometric assays. The hook
effect. J Endocrinol Invest. 21:184–188. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Romijn JA: Hyperprolactinemia and
prolactinoma. Handb Clin Neurol. 124:185–195. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Vilar L, Freitas MC, Naves LA, Casulari
LA, Azevedo M, Montenegro R Jr, Barros AI, Faria M, Nascimento GC,
Lima JG, et al: Diagnosis and management of hyperprolactinemia:
Results of a Brazilian multicenter study with 1234 patients. J
Endocrinol Invest. 31:436–444. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Paepegaey AC, Veron L, Wimmer MC and
Christin-Maitre S: Misleading diagnosis of hyperprolactinemia in
women. Gynecol Obstet Fertil. 44:181–186. 2016.(In French).
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kawaguchi T, Ogawa Y and Tominaga T:
Diagnostic pitfalls of hyperprolactinemia: The importance of
sequential pituitary imaging. BMC Res Notes. 7:5552014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ross RJ, Grossman A, Bouloux P, Rees LH,
Doniach I and Besser GM: The relationship between serum prolactin
and immunocytochemical staining for prolactin in patients with
pituitary macroadenomas. Clin Endocrinol (Oxf). 23:227–235. 1985.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Arafah BM, Nekl KE, Gold RS and Selman WR:
Dynamics of prolactin secretion in patients with hypopituitarism
and pituitary macroadenomas. J Clin Endocrinol Metab. 80:3507–3512.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pala NA, Laway BA, Misgar RA and Dar RA:
Metabolic abnormalities in patients with prolactinoma: Response to
treatment with cabergoline. Diabetol Metab Syndr. 7:992015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wong A, Eloy JA, Couldwell WT and Liu JK:
Update on prolactinomas. Part. 2:Treatment and management
strategies. J Clin Neurosci 22: 1568–1574. 2015.
|
|
33
|
Menucci M, Quinones-Hinojosa A, Burger P
and Salvatori R: Effect of dopaminergic drug treatment on surgical
findings in prolactinomas. Pituitary. 14:68–74. 2011. View Article : Google Scholar : PubMed/NCBI
|
